Pivotal US trial of the folate-containing oral contraceptive SAFRYL

Trial Profile

Pivotal US trial of the folate-containing oral contraceptive SAFRYL

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2010

At a glance

  • Drugs Drospirenone/ethinylestradiol; Ethinylestradiol/drospirenone/levomefolic acid
  • Indications Pregnancy
  • Focus Pharmacodynamics; Registrational
  • Sponsors Bayer
  • Most Recent Events

    • 17 Dec 2010 Based on the results of this pivotal study, the oral contraceptive ethinylestradiol/drospirenone/levomefolic-acid (Safyral) has been approved by the US FDA, according to a Bayer media release.
    • 16 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top